The beneficial effects of a partial loss of function of JNK1 in a genetic model of Alzheimer’s disease (APP/PS1/Jnk1±) was reported in the past by our research group (Petrov et al. 2015). The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.